Valitor

Series-B
valitorbio.com Biotech & Healthcare
Total Funding $28M
Latest Round $28M Series-B
Last Announced Oct 5, 2022
Investors Undisclosed
Decision Makers 5 Available

About Valitor

Valitor is initially focused on improving patient outcomes in ophthalmology and vision-threatening diseases by conquering long-standing limitations of traditional biologic medicines.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website valitorbio.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $28,000,000 · Series-B

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Valitor.

Funding History

1 Round
Series-B equity · Oct 5, 2022

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts